ALIGN TECHNOLOGY, INC. Income (Loss) from Equity Method Investments
ALIGN TECHNOLOGY, INC. (ALGN) reported Income (Loss) from Equity Method Investments of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2022-02-25
- ALIGN TECHNOLOGY, INC. income (loss) from equity method investments for the quarter ending 2020-12-31 was $0.00.
- ALIGN TECHNOLOGY, INC. income (loss) from equity method investments for the quarter ending 2020-09-30 was $0.00.
- ALIGN TECHNOLOGY, INC. income (loss) from equity method investments for the quarter ending 2020-06-30 was $0.00.
- ALIGN TECHNOLOGY, INC. income (loss) from equity method investments for the quarter ending 2020-03-31 was $0.00.
- ALIGN TECHNOLOGY, INC. income (loss) from equity method investments for fiscal 2021 was $0.00.
- ALIGN TECHNOLOGY, INC. income (loss) from equity method investments for fiscal 2020 was $0.00.
- ALIGN TECHNOLOGY, INC. income (loss) from equity method investments for fiscal 2019 was -$7.53M.
- ALIGN TECHNOLOGY, INC. income (loss) from equity method investments for fiscal 2018 was -$8.69M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-25 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | $0.00 10-K · filed 2022-02-25 |
| 2020-09-30 | $0.00 10-Q · filed 2020-10-30 | $0.00 derived: sum of 2 quarters · filed 2020-10-30 | $0.00 10-Q · filed 2020-10-30 | $0.00 derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $0.00 10-Q · filed 2020-07-31 | $0.00 10-Q · filed 2020-07-31 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | $0.00 derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-05 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | -$3.58M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | -$3.58M derived: sum of 3 quarters · filed 2022-02-25 | -$7.53M 10-K · filed 2022-02-25 |
| 2019-09-30 | $0.00 10-Q · filed 2020-10-30 | -$3.58M derived: sum of 2 quarters · filed 2020-10-30 | -$7.53M 10-Q · filed 2020-10-30 | -$9.61M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$3.58M 10-Q · filed 2020-07-31 | -$7.53M 10-Q · filed 2020-07-31 | -$9.61M derived: sum of 3 quarters · filed 2021-02-26 | -$10.74M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$3.94M 10-Q · filed 2020-05-05 | -$6.03M derived: sum of 2 quarters · filed 2021-02-26 | -$7.16M derived: sum of 3 quarters · filed 2021-02-26 | -$10.86M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$3.21M derived: sum of 2 quarters · filed 2021-02-26 | -$6.92M derived: sum of 3 quarters · filed 2021-02-26 | -$8.69M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$1.13M 10-Q · filed 2019-10-31 | -$4.83M derived: sum of 2 quarters · filed 2019-10-31 | -$6.61M 10-Q · filed 2019-10-31 | -$4.88M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$3.70M 10-Q · filed 2019-08-01 | -$5.48M 10-Q · filed 2019-08-01 | -$3.75M derived: sum of 3 quarters · filed 2020-02-28 | -$5.36M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | -$1.78M 10-Q · filed 2019-05-02 | -$46.00K derived: sum of 2 quarters · filed 2020-02-28 | -$1.66M derived: sum of 3 quarters · filed 2020-02-28 | -$3.88M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $117.00K derived: sum of 2 quarters · filed 2020-02-28 | -$2.10M derived: sum of 3 quarters · filed 2020-02-28 | -$3.22M 10-K · filed 2020-02-28 |
| 2017-09-30 | -$1.61M 10-Q · filed 2018-11-01 | -$3.83M derived: sum of 2 quarters · filed 2018-11-01 | -$4.95M 10-Q · filed 2018-11-01 | -$6.16M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$2.21M 10-Q · filed 2018-08-02 | -$3.34M 10-Q · filed 2018-08-02 | -$4.54M derived: sum of 3 quarters · filed 2019-02-28 | -$5.02M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$1.12M 10-Q · filed 2018-05-03 | -$2.33M derived: sum of 2 quarters · filed 2019-02-28 | -$2.81M derived: sum of 3 quarters · filed 2019-02-28 | -$2.81M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$1.68M derived: sum of 2 quarters · filed 2019-02-28 | -$1.68M derived: sum of 3 quarters · filed 2019-02-28 | -$1.68M 10-K · filed 2019-02-28 |
| 2016-09-30 | -$477.00K 10-Q · filed 2017-11-02 | -$477.00K derived: sum of 2 quarters · filed 2017-11-02 | -$477.00K 10-Q · filed 2017-11-02 | -$477.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 10-K · filed 2018-02-28 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-08 | $0.00 10-Q · filed 2016-11-08 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |